A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation

Mei Chena Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China; ;b Department of Ophthalmology, Dazhou Central Hospital, Dazhou, Sichuan, China;

Jiangping Houa Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China; ;c Department of Ophthalmology, Provincial Hospital Affiliated to Shandong University, Jinan City, Shandong, China;

Guilin Tana Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China;

Peng Xiea Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China;

William R. Freemand Jacobs Retina Center at Shiley Eye Center, Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA;

James R. Beadlee Department of Medicine, University of California, San Diego and the San Diego Veterans Medical Research Foundation, La Jolla, CA, USA

Karl Y. Hostetlere Department of Medicine, University of California, San Diego and the San Diego Veterans Medical Research Foundation, La Jolla, CA, USA

Lingyun Chenga Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China; ;d Jacobs Retina Center at Shiley Eye Center, Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA; Correspondence[email protected]

show all

A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation

IDRD_Cheng_et_al_Supplemental_Content.zip

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation

IDRD_Cheng_et_al_Supplemental_Content.zip

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date